Table 5

Secondary outcomes (QoL, tests of physical performance and strength)

OutcomeCycling (n=8)Weights (n=7)Combined (n=8)Stretching/control (n=8)
PCS
 Mean difference and SD5.2±9.34.1±8.01.7±7.43.4±7.3
 Main effects (95% CI)Cycling vs no cycling
−0.076 (−5.9 to 5.8); p=0.979
Weights vs no weights
−1.82 (−7.7 to 4.1); p=0.53
MCS
 Mean difference and SD−2.3±10.7−3.4±9.1−1.5±5.90.70±7.5
 Main effects (95% CI)Cycling vs no cycling
0.23 (−6.0 to 6.5); p=0.94
Weights vs no weights
0.21 (−6.5 to 6.9); p=0.95
SPPB
 Mean difference and SD1.9±2.41.4±1.91.0±1.20.63±1.2
 Main effects (95% CI)*Cycling vs no cycling
1.7 (0.2 to 3.3) p=0.028
Weights vs no weights
1.6 (0.05 to 3.2) p=0.044
6MWT
 Mean difference and SD42.3±88.854.9±52.939.0±76.80.8±44.0
 Main effects (95% CI)Cycling vs no cycling
12.8 (−36.1 to 61.6) p=0.60
Weights vs no weights
30.7 (−17.8 to 79.2) p=0.21
STS 30 s
 Mean difference and SD0.9±2.21.6±2.71.4±3.51.4±4.3
 Main effects (95% CI)Cycling vs no cycling
−0.31 (−2.7 to 2.1) p=0.79
Weights vs no weights
0.42 (−2.0 to 2.8) p=0.73
1-RM
 Mean difference and SD11.6±10.78.9±5.54.9±11.69.3±10.1
 Main effects (95% CI)Cycling vs no cycling
−3.4 (−11.0 to 4.2) p=0.37
Weights vs no weights
−2.8 (−9.9 to 4.2) p=0.42
  • 1-RM, one repetition maximum; 6MWT, 6 min walk test; MCS, mental component score; PCS, physical component score); QoL, quality of life; SPPB, short physical performance battery; STS 30 s, 30 s sit-to-stand.

  • Models are adjusted for baseline score and the other main effect term.

  • *Interaction term included in the model (p=0.026).